RA
MEDP icon

Royce & Associates’s Medpace MEDP Stock Holding History

Royce & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,713
Closed -$3.93M – 902
2024
Q1 		$3.93M Sell
9,713
-787
-7% -$277K 0.04% 544
2023
Q4 		$3.22M Buy
+10,500
New +$2.83M 0.03% 577
2022
Q1 		– Sell
-15,000
Closed -$3.27M – 1000
2021
Q4 		$3.27M Hold
15,000
– – 0.02% 643
2021
Q3 		$2.84M Sell
15,000
-568
-4% -$104K 0.02% 691
2021
Q2 		$2.75M Hold
15,568
– – 0.02% 716
2021
Q1 		$2.55M Sell
15,568
-3,599
-19% -$550K 0.02% 718
2020
Q4 		$2.67M Hold
19,167
– – 0.02% 676
2020
Q3 		$2.14M Hold
19,167
– – 0.02% 666
2020
Q2 		$1.78M Hold
19,167
– – 0.02% 690
2020
Q1 		$1.41M Hold
19,167
– – 0.02% 676
2019
Q4 		$1.61M Buy
19,167
+556
+3% +$43K 0.01% 735
2019
Q3 		$1.56M Buy
18,611
+14,611
+365% +$1.1M 0.01% 747
2019
Q2 		$262K Hold
4,000
– – ﹤0.01% 976
2019
Q1 		$236K Buy
+4,000
New +$239K ﹤0.01% 991

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Royce & Associates's MEDP Position: Q2 2024 in Review

Royce & Associates sold out of Medpace (MEDP) in Q2 2024, closing a stake of 9,713 shares — an estimated $3.93M sold.

Royce & Associates first reported a position in MEDP in Q1 2019 and held it in 14 quarters. The position peaked at $3.93M in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Royce & Associates reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • Royce & Associates sold 9,713 Medpace shares in Q2 2024, an estimated $3.93M.
  • Royce & Associates first reported a position in Medpace in Q1 2019 and held it in 14 quarters.
  • Royce & Associates's Medpace position peaked at $3.93M in Q1 2024.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.